Corteva Inc (CTVA) Q3 2026 Earnings Call Transcript

Corteva Inc. (CTVA) reported Q3 2026 earnings, with net sales at $1.6B, down 9% YoY, and operating EBITDA at $222M, down 17%. Growth was seen in North America, EMEA, and Asia Pacific, but Latin America sales dropped 31% due to market challenges. The company maintained flat EBITDA levels YoY and expanded margins despite $230M in pricing headwinds. Corteva declared its first quarterly dividend and remains on track for a year-end cash position of $1.5B.

Original reporting
Published Nov 12, 2026, 9:31 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 9:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Corteva Inc (CTVA) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$CTVABearishMed
01

Why it matters

The earnings miss and Brazil challenges may trigger short‑term sell pressure, but the dividend launch and stable EBITDA could attract income‑focused investors.

02

Market read

First public disclosure of Q3 2026 results; material financial figures and regional outlook affect stock valuation.

03

What to watch

Strong growth in North America, EMEA, and APAC offset Brazil weakness; new R&D spend may drive future upside.

Relevance 8/10Novelty 8/10Timing: post‑earnings release today

Background

Corteva, a leading crop‑protection company, reported its Q3 2026 earnings via a transcript, highlighting regional performance and pricing headwinds.

Company-level read

Ticker impact

$CTVABearishHigh confidence
Context

Q3 2026 earnings call disclosed net sales of $1.6B (down 9%), operating EBITDA $222M (down 17%) and highlighted Brazil market weakness.

Expected impact

likely downside as investors price in weaker Brazil outlook and lower EBITDA

Evidence & confidence

First disclosure of Q3 results with material miss; guidance uncertainty for full year adds risk.

Market effects

Agricultural chemicals sector may see broader scrutiny of pricing pressure and Brazil exposure.

Latin America, especially Brazil, could face weaker agribusiness earnings.

Limited to investors in crop protection and fertilizer markets.

Counterpoint

Dividend initiation and flat EBITDA suggest resilience; could be a buying opportunity on dip.

Key entities

  • Corteva Inc

    US‑listed agricultural chemicals producer (CTVA).

Related articles

$CTVAHighAI 9/10

Why is Corteva stock plunging today?

Corteva stock fell 18.8% to $9.86, hitting a 52-week low of $9.14, after Q3 results missed estimates and the company cut its 2026 profit outlook, citing Brazil's agricultural chemicals market. Adjusted EPS was $0.06 vs. $0.10 estimate, and revenue was $1.59B, down 9% YoY. The company was also removed from the MSCI USA Index, adding to selling pressure.

$CTVAHighAI 8/10

Why Corteva Stock Dropped on Thursday

Corteva (CTVA) shares fell 20.2% after Q3 earnings missed estimates. The company reported $0.06 EPS and $1.6B revenue, citing price declines in agricultural chemicals. Revenue grew in North America, Europe, and Asia but dropped 28% in Latin America. Corteva expects challenging market conditions, particularly in Brazil.

$CTVAHighAI 8/10

Corteva shares slide after Brazil weakness prompts annual profit forecast cut

Corteva's shares fell to a 1-year low after cutting its annual profit forecast due to Brazilian market weakness. The company now expects adjusted profit of $0.76-$0.80 per share, down from $3.60-$3.80. Shares dropped 22.8% to $9.36, the steepest loss on record. Corteva cited farmer liquidity constraints and higher financing costs in Brazil. Analysts expect volatility due to the crop protection market's cyclicality.